Richard Jonathan Cohen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 38 | 2019 | 981 | 2.730 |
Why?
|
| Tachycardia, Ventricular | 21 | 2021 | 1309 | 1.860 |
Why?
|
| Electrocardiography | 51 | 2013 | 6412 | 1.760 |
Why?
|
| Body Surface Potential Mapping | 10 | 2019 | 228 | 1.730 |
Why?
|
| Arrhythmias, Cardiac | 29 | 2015 | 2258 | 1.590 |
Why?
|
| Baroreflex | 10 | 2004 | 154 | 1.580 |
Why?
|
| Heart Rate | 53 | 2013 | 4214 | 1.470 |
Why?
|
| Cardiac Output | 10 | 2019 | 838 | 1.430 |
Why?
|
| Signal Processing, Computer-Assisted | 21 | 2014 | 1489 | 1.370 |
Why?
|
| Heart Conduction System | 21 | 2013 | 1009 | 1.310 |
Why?
|
| Vascular Resistance | 9 | 2019 | 939 | 1.290 |
Why?
|
| Catheter Ablation | 11 | 2022 | 2780 | 1.110 |
Why?
|
| Ventricular Fibrillation | 14 | 2008 | 537 | 1.050 |
Why?
|
| Blood Pressure | 26 | 2019 | 8543 | 0.940 |
Why?
|
| Autonomic Nervous System | 18 | 2005 | 707 | 0.910 |
Why?
|
| Hypotension, Orthostatic | 8 | 2006 | 258 | 0.820 |
Why?
|
| Algorithms | 39 | 2021 | 14164 | 0.790 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2012 | 1567 | 0.730 |
Why?
|
| Bed Rest | 10 | 2005 | 83 | 0.720 |
Why?
|
| Nonlinear Dynamics | 12 | 2002 | 493 | 0.700 |
Why?
|
| Defibrillators, Implantable | 9 | 2015 | 1498 | 0.700 |
Why?
|
| Computer Simulation | 25 | 2013 | 6283 | 0.660 |
Why?
|
| Weightlessness Simulation | 6 | 2006 | 41 | 0.660 |
Why?
|
| Electrocardiography, Ambulatory | 7 | 2008 | 582 | 0.630 |
Why?
|
| Sus scrofa | 1 | 2019 | 430 | 0.580 |
Why?
|
| Sympathetic Nervous System | 8 | 2013 | 521 | 0.540 |
Why?
|
| Blood Pressure Determination | 2 | 2012 | 646 | 0.490 |
Why?
|
| Heart | 13 | 2021 | 4446 | 0.470 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2010 | 709 | 0.460 |
Why?
|
| Cardiovascular Physiological Phenomena | 9 | 2001 | 241 | 0.450 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2013 | 1003 | 0.400 |
Why?
|
| Stroke Volume | 8 | 2019 | 5622 | 0.390 |
Why?
|
| Pressoreceptors | 2 | 2001 | 99 | 0.360 |
Why?
|
| Models, Biological | 12 | 2012 | 9495 | 0.350 |
Why?
|
| Electrophysiology | 14 | 1999 | 1266 | 0.350 |
Why?
|
| Exercise Test | 8 | 2013 | 2186 | 0.350 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1375 | 0.300 |
Why?
|
| Swine | 9 | 2022 | 5995 | 0.300 |
Why?
|
| Weightlessness | 2 | 2005 | 103 | 0.290 |
Why?
|
| Heart Ventricles | 6 | 2012 | 3841 | 0.280 |
Why?
|
| Arrhythmia, Sinus | 2 | 2001 | 48 | 0.270 |
Why?
|
| Hypotension | 1 | 2013 | 888 | 0.270 |
Why?
|
| Hemodynamics | 7 | 2013 | 4194 | 0.270 |
Why?
|
| Respiration | 7 | 2001 | 1665 | 0.270 |
Why?
|
| Ventricular Function | 5 | 2002 | 405 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2012 | 1361 | 0.270 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 1997 | 881 | 0.260 |
Why?
|
| Physiology | 1 | 2006 | 112 | 0.260 |
Why?
|
| Parasympathetic Nervous System | 5 | 2003 | 144 | 0.250 |
Why?
|
| Posture | 8 | 1999 | 957 | 0.250 |
Why?
|
| Reproducibility of Results | 14 | 2019 | 20227 | 0.250 |
Why?
|
| Aorta | 2 | 2012 | 2045 | 0.250 |
Why?
|
| Head-Down Tilt | 8 | 2006 | 67 | 0.250 |
Why?
|
| Syncope | 2 | 2005 | 430 | 0.250 |
Why?
|
| Autonomic Nerve Block | 2 | 1997 | 82 | 0.250 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1312 | 0.240 |
Why?
|
| Monitoring, Physiologic | 5 | 2006 | 1798 | 0.230 |
Why?
|
| Linear Models | 6 | 1997 | 5884 | 0.220 |
Why?
|
| Least-Squares Analysis | 7 | 2008 | 367 | 0.220 |
Why?
|
| Blood Circulation | 4 | 2004 | 248 | 0.220 |
Why?
|
| Tilt-Table Test | 5 | 2005 | 80 | 0.220 |
Why?
|
| Sensitivity and Specificity | 11 | 2013 | 14729 | 0.220 |
Why?
|
| Homeostasis | 2 | 2004 | 3348 | 0.210 |
Why?
|
| Catheters | 3 | 2022 | 427 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2013 | 2145 | 0.210 |
Why?
|
| Midodrine | 2 | 2006 | 24 | 0.210 |
Why?
|
| Propranolol | 8 | 2001 | 493 | 0.200 |
Why?
|
| Leg | 3 | 2005 | 1088 | 0.200 |
Why?
|
| Space Simulation | 1 | 2001 | 9 | 0.190 |
Why?
|
| Models, Anatomic | 2 | 2008 | 680 | 0.190 |
Why?
|
| Atropine | 6 | 2001 | 244 | 0.190 |
Why?
|
| Liver Transplantation | 1 | 2013 | 2401 | 0.180 |
Why?
|
| Lung Volume Measurements | 7 | 1999 | 381 | 0.180 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.180 |
Why?
|
| Humans | 102 | 2022 | 768166 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2709 | 0.170 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 4 | 2012 | 511 | 0.170 |
Why?
|
| Models, Statistical | 5 | 2006 | 5107 | 0.170 |
Why?
|
| Myocardial Infarction | 5 | 2003 | 11519 | 0.170 |
Why?
|
| Risk Assessment | 10 | 2012 | 24315 | 0.170 |
Why?
|
| Animals | 38 | 2022 | 169246 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2003 | 843 | 0.160 |
Why?
|
| Torsades de Pointes | 1 | 2000 | 78 | 0.160 |
Why?
|
| Cardiovascular System | 5 | 2004 | 841 | 0.160 |
Why?
|
| Supine Position | 5 | 2001 | 208 | 0.160 |
Why?
|
| Dogs | 12 | 1997 | 3845 | 0.160 |
Why?
|
| Tachycardia | 2 | 1998 | 599 | 0.150 |
Why?
|
| Motion Sickness | 1 | 1998 | 33 | 0.150 |
Why?
|
| Parasympatholytics | 1 | 1997 | 89 | 0.140 |
Why?
|
| Scopolamine | 1 | 1997 | 93 | 0.140 |
Why?
|
| Liver | 1 | 2013 | 7577 | 0.140 |
Why?
|
| Models, Animal | 2 | 2001 | 2120 | 0.140 |
Why?
|
| Normal Distribution | 2 | 2008 | 272 | 0.140 |
Why?
|
| Ventricular Premature Complexes | 1 | 1997 | 112 | 0.140 |
Why?
|
| Muscarinic Antagonists | 1 | 1997 | 136 | 0.130 |
Why?
|
| Atrial Function, Right | 3 | 2004 | 32 | 0.130 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 152 | 0.130 |
Why?
|
| Biophysics | 1 | 1997 | 379 | 0.130 |
Why?
|
| Male | 52 | 2015 | 364719 | 0.120 |
Why?
|
| Sheep | 3 | 2004 | 1451 | 0.120 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.120 |
Why?
|
| Death, Sudden | 1 | 1996 | 301 | 0.120 |
Why?
|
| Bioelectric Energy Sources | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sudden Infant Death | 2 | 1987 | 293 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 1997 | 407 | 0.120 |
Why?
|
| Predictive Value of Tests | 10 | 2008 | 15454 | 0.120 |
Why?
|
| Prealbumin | 1 | 2016 | 259 | 0.110 |
Why?
|
| Adult | 41 | 2015 | 223646 | 0.110 |
Why?
|
| Endocrine System | 2 | 2005 | 113 | 0.110 |
Why?
|
| Heart Failure | 5 | 2012 | 11879 | 0.110 |
Why?
|
| Purkinje Fibers | 1 | 1993 | 31 | 0.110 |
Why?
|
| Equipment Design | 3 | 2022 | 3522 | 0.110 |
Why?
|
| Kinetics | 6 | 2016 | 6329 | 0.110 |
Why?
|
| Feedback | 2 | 1997 | 799 | 0.110 |
Why?
|
| Atrioventricular Node | 1 | 1994 | 180 | 0.110 |
Why?
|
| Bundle of His | 1 | 1993 | 102 | 0.100 |
Why?
|
| Models, Neurological | 2 | 2003 | 1776 | 0.100 |
Why?
|
| Phantoms, Imaging | 2 | 2013 | 2512 | 0.100 |
Why?
|
| Electric Countershock | 1 | 2015 | 534 | 0.100 |
Why?
|
| Body Surface Area | 1 | 1992 | 205 | 0.100 |
Why?
|
| Plaque, Amyloid | 1 | 2016 | 769 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2016 | 406 | 0.100 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 1997 | 192 | 0.100 |
Why?
|
| Protein Denaturation | 1 | 2012 | 242 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2012 | 235 | 0.090 |
Why?
|
| Gadolinium | 1 | 2016 | 964 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 464 | 0.090 |
Why?
|
| Pressure | 2 | 2004 | 1172 | 0.090 |
Why?
|
| Bundle-Branch Block | 1 | 1992 | 278 | 0.090 |
Why?
|
| Electric Impedance | 1 | 1995 | 794 | 0.090 |
Why?
|
| Heart Transplantation | 3 | 1996 | 3301 | 0.090 |
Why?
|
| Ovalbumin | 1 | 2012 | 677 | 0.090 |
Why?
|
| Renin | 4 | 2005 | 648 | 0.080 |
Why?
|
| Atrial Function | 3 | 2000 | 98 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2006 | 6340 | 0.080 |
Why?
|
| Mathematics | 4 | 1997 | 704 | 0.080 |
Why?
|
| Plethysmography | 2 | 2005 | 172 | 0.080 |
Why?
|
| Female | 34 | 2016 | 397192 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3436 | 0.070 |
Why?
|
| Reflex | 1 | 1990 | 375 | 0.070 |
Why?
|
| Protein Folding | 1 | 2012 | 871 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2008 | 2923 | 0.070 |
Why?
|
| Coronary Disease | 6 | 1997 | 5919 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 3 | 2000 | 1627 | 0.070 |
Why?
|
| Endocytosis | 1 | 2012 | 956 | 0.070 |
Why?
|
| Stochastic Processes | 4 | 2003 | 360 | 0.070 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2001 | 270 | 0.070 |
Why?
|
| Middle Aged | 24 | 2015 | 223492 | 0.070 |
Why?
|
| Ligands | 3 | 2012 | 3284 | 0.070 |
Why?
|
| Endocardium | 1 | 1988 | 249 | 0.070 |
Why?
|
| Immobilization | 2 | 2006 | 229 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 2003 | 1525 | 0.070 |
Why?
|
| Spectrum Analysis | 3 | 1997 | 449 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6847 | 0.060 |
Why?
|
| Reference Values | 5 | 2001 | 4938 | 0.060 |
Why?
|
| Feasibility Studies | 4 | 2003 | 5315 | 0.060 |
Why?
|
| Fourier Analysis | 4 | 1993 | 439 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 95 | 0.060 |
Why?
|
| Disease Susceptibility | 4 | 2004 | 1793 | 0.060 |
Why?
|
| Muscles | 1 | 1990 | 1582 | 0.060 |
Why?
|
| Exercise | 3 | 1997 | 5955 | 0.060 |
Why?
|
| Peptides | 2 | 2016 | 4354 | 0.060 |
Why?
|
| Heart Diseases | 1 | 1997 | 2819 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 9343 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5151 | 0.050 |
Why?
|
| Atrial Flutter | 1 | 2006 | 253 | 0.050 |
Why?
|
| Hippocampus | 1 | 2016 | 3785 | 0.050 |
Why?
|
| Heart Arrest | 2 | 2003 | 1516 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 1996 | 2056 | 0.050 |
Why?
|
| Binding Sites | 1 | 2012 | 6020 | 0.050 |
Why?
|
| Pericardium | 1 | 1988 | 679 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2006 | 948 | 0.050 |
Why?
|
| Space Flight | 1 | 2005 | 219 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 3914 | 0.050 |
Why?
|
| Myocardium | 4 | 2003 | 4788 | 0.050 |
Why?
|
| Haptens | 2 | 1993 | 163 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3655 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 656 | 0.050 |
Why?
|
| Steam | 1 | 2022 | 33 | 0.050 |
Why?
|
| Prognosis | 6 | 2012 | 30010 | 0.050 |
Why?
|
| Aldosterone | 2 | 2005 | 881 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1500 | 0.050 |
Why?
|
| Aged | 16 | 2015 | 171504 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 39348 | 0.050 |
Why?
|
| Observer Variation | 1 | 2008 | 2622 | 0.050 |
Why?
|
| Action Potentials | 4 | 2003 | 1838 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2008 | 1188 | 0.050 |
Why?
|
| Electrodes | 2 | 2014 | 617 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2022 | 297 | 0.040 |
Why?
|
| Kidney | 3 | 2005 | 7064 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2001 | 320 | 0.040 |
Why?
|
| Catheterization | 1 | 2006 | 1430 | 0.040 |
Why?
|
| Carotid Sinus | 1 | 2000 | 44 | 0.040 |
Why?
|
| Quality Control | 1 | 2003 | 836 | 0.040 |
Why?
|
| Lung | 4 | 2000 | 10099 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2002 | 585 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2003 | 770 | 0.040 |
Why?
|
| Sodium | 4 | 2005 | 1597 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2004 | 1841 | 0.040 |
Why?
|
| Time Factors | 10 | 2013 | 40218 | 0.040 |
Why?
|
| Hemorrhage | 1 | 1991 | 3467 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 1999 | 192 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 1985 | 1617 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 1014 | 0.040 |
Why?
|
| Antigens | 2 | 1995 | 1442 | 0.040 |
Why?
|
| Melatonin | 1 | 2003 | 670 | 0.040 |
Why?
|
| Biomedical Engineering | 1 | 1999 | 286 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 1998 | 317 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2015 | 54926 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 848 | 0.040 |
Why?
|
| Glycopyrrolate | 2 | 1991 | 35 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2001 | 775 | 0.040 |
Why?
|
| Risk Factors | 6 | 2008 | 74944 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2002 | 1259 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1988 | 2138 | 0.030 |
Why?
|
| Hypothermia, Induced | 3 | 1988 | 754 | 0.030 |
Why?
|
| Tetralogy of Fallot | 1 | 2002 | 628 | 0.030 |
Why?
|
| Thorax | 1 | 2000 | 557 | 0.030 |
Why?
|
| Vena Cava, Inferior | 1 | 2000 | 463 | 0.030 |
Why?
|
| Vagus Nerve | 2 | 1989 | 459 | 0.030 |
Why?
|
| Nitroprusside | 2 | 1990 | 272 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1997 | 320 | 0.030 |
Why?
|
| Rotation | 1 | 1998 | 517 | 0.030 |
Why?
|
| Recurrence | 2 | 1998 | 8509 | 0.030 |
Why?
|
| Potassium | 3 | 2005 | 1315 | 0.030 |
Why?
|
| Long QT Syndrome | 1 | 2000 | 472 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 272 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2003 | 2932 | 0.030 |
Why?
|
| Diabetic Neuropathies | 1 | 1999 | 410 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1997 | 716 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1995 | 1353 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8759 | 0.030 |
Why?
|
| Anisotropy | 1 | 1998 | 1292 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1681 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 10266 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1994 | 370 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1997 | 1090 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 1989 | 1741 | 0.030 |
Why?
|
| Oligopeptides | 2 | 1994 | 1194 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1995 | 518 | 0.030 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1993 | 63 | 0.030 |
Why?
|
| Plethysmography, Impedance | 1 | 1993 | 44 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1993 | 342 | 0.030 |
Why?
|
| Dinitrophenols | 1 | 1992 | 56 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 309 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2593 | 0.020 |
Why?
|
| Heart Atria | 1 | 1997 | 1361 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1996 | 1826 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1991 | 407 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1991 | 243 | 0.020 |
Why?
|
| Mice | 3 | 2016 | 82029 | 0.020 |
Why?
|
| Nerve Block | 1 | 1997 | 716 | 0.020 |
Why?
|
| Renin-Angiotensin System | 2 | 2005 | 737 | 0.020 |
Why?
|
| Veins | 2 | 2004 | 769 | 0.020 |
Why?
|
| Periodicity | 1 | 1991 | 348 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2945 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 8054 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1990 | 292 | 0.020 |
Why?
|
| Oscillometry | 1 | 1989 | 151 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1995 | 1801 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1995 | 2568 | 0.020 |
Why?
|
| Adolescent | 6 | 2002 | 89169 | 0.020 |
Why?
|
| Artifacts | 1 | 1996 | 1926 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18349 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1990 | 898 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1996 | 1334 | 0.020 |
Why?
|
| Reaction Time | 1 | 1993 | 2101 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2003 | 2678 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1998 | 10101 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9263 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12840 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1991 | 2089 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2000 | 12077 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 2004 | 101 | 0.010 |
Why?
|
| Antibodies | 1 | 1992 | 2421 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9561 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7598 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2004 | 208 | 0.010 |
Why?
|
| Tropomyosin | 1 | 2003 | 106 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 41754 | 0.010 |
Why?
|
| Survivors | 1 | 1994 | 2381 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2006 | 12465 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1993 | 5902 | 0.010 |
Why?
|
| Teprotide | 1 | 1981 | 25 | 0.010 |
Why?
|
| Risk | 1 | 1994 | 9613 | 0.010 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2004 | 301 | 0.010 |
Why?
|
| Differential Threshold | 1 | 2001 | 80 | 0.010 |
Why?
|
| Clone Cells | 2 | 1995 | 1670 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6526 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 1066 | 0.010 |
Why?
|
| Angiotensins | 1 | 1981 | 141 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2003 | 380 | 0.010 |
Why?
|
| Software | 1 | 1995 | 4478 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 8128 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1994 | 4648 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 59629 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1999 | 220 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1999 | 194 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 662 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1999 | 530 | 0.010 |
Why?
|
| Computers | 1 | 1981 | 592 | 0.010 |
Why?
|
| Cardiology | 1 | 1989 | 1702 | 0.010 |
Why?
|
| Biopsy | 1 | 1989 | 6793 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1988 | 9384 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4473 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 2064 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1667 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1989 | 4492 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 23760 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2643 | 0.010 |
Why?
|
| Infant | 2 | 1987 | 36535 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6229 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 2981 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5777 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 13421 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2013 | 65371 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 877 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1993 | 361 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1083 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 17622 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10632 | 0.010 |
Why?
|
| Polymers | 1 | 1999 | 1630 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30238 | 0.010 |
Why?
|
| Pyridinium Compounds | 1 | 1991 | 81 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1981 | 3728 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1994 | 960 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1991 | 1310 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1998 | 81762 | 0.010 |
Why?
|
| Epitopes | 1 | 1995 | 2528 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 693 | 0.000 |
Why?
|
| Cell Hypoxia | 1 | 1991 | 662 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36743 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12543 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 1930 | 0.000 |
Why?
|
| Aging | 1 | 1999 | 8744 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1990 | 9015 | 0.000 |
Why?
|
| Child | 1 | 2001 | 80917 | 0.000 |
Why?
|